Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced positive top-line results from the first of two pivotal phase 3 clinical trials ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News

Synergy (SGYP) PT Lifted to $19 at Canaccord Genuity; 'This Thang Don't Stank'June 18, 2015 9:50 AM Synergy (SGYP) Seen as Attractive Takeout Target at Cantor Fitzgerald; PT Up to $14June 17, 2015 11:38 AM Synergy Pharmaceuticals Announces Positive Results in the First Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation (CIC)June 17, 2015 6:00 AM